Is there an association between anti-TNF monoclonal antibody therapy in rheumatoid arthritis and risk of malignancy and serious infection? Commentary on the meta-analysis by Bongartz et al

A recent meta-analysis of randomized clinical trials reported by Bongartz and coworkers raised concerns about an increased rate of malignancy and serious infection in rheumatoid arthritis patients treated with anti-tumour necrosis factor monoclonal antibodies. This commentary discusses some of the m...

Descripción completa

Detalles Bibliográficos
Autores principales: Dixon, Will, Silman, Alan
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2006
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1779433/
https://www.ncbi.nlm.nih.gov/pubmed/16911768
http://dx.doi.org/10.1186/ar2026

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1779433/
https://www.ncbi.nlm.nih.gov/pubmed/16911768
http://dx.doi.org/10.1186/ar2026

Ejemplares similares